Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -31.74%34.41B | 124.97%50.41B | 30.70%22.41B | 54.01%17.14B | -27.92%11.13B | 24.07%15.44B | 19.54%12.45B | 75.97%10.41B | -35.37%5.92B | 85.57%9.16B |
Net profit before non-cash adjustment | -37.81%26.15B | 24.94%42.04B | 198.09%33.65B | 218.81%11.29B | -37.25%3.54B | 2.57%5.64B | 7.55%5.5B | 52.38%5.11B | 353.45%3.36B | -164.07%-1.32B |
Total adjustment of non-cash items | 51.06%20.58B | 1,001.06%13.62B | -119.72%-1.51B | -19.64%7.67B | 1.70%9.54B | 76.78%9.38B | 7.93%5.31B | -11.63%4.92B | -26.01%5.56B | 87.49%7.52B |
-Depreciation and amortization | 30.14%16.66B | 57.00%12.8B | -11.17%8.16B | 18.55%9.18B | 29.12%7.74B | 30.78%6B | 20.99%4.59B | -15.00%3.79B | 8.38%4.46B | -4.80%4.11B |
-Reversal of impairment losses recognized in profit and loss | --424M | --0 | -80.76%404M | 158.40%2.1B | -66.55%812.7M | 898.05%2.43B | 5.95%243.4M | -44.67%229.74M | -87.42%415.25M | 713.09%3.3B |
-Share of associates | 7,495.12%3.03B | 99.56%-41M | -68.61%-9.31B | -1,213.92%-5.52B | 24.44%-420.42M | -69.40%-556.41M | -37.79%-328.46M | -67.20%-238.37M | 19.10%-142.57M | -465.94%-176.24M |
-Disposal profit | -252.93%-1.33B | -840.00%-376M | 76.05%-40M | -1,560.30%-167M | -95.88%11.44M | 47.94%277.83M | -35.33%187.8M | 42,170.01%290.4M | -88.23%687K | 100.44%5.84M |
-Net exchange gains and losses | 43.08%-798M | 30.80%-1.4B | -2,151.11%-2.03B | -131.44%-90M | -40.49%286.29M | 458.82%481.11M | -133.42%-134.08M | 67.29%401.18M | 187.75%239.82M | 73.28%-273.28M |
-Remuneration paid in stock | -14.38%375M | 33.54%438M | 180.34%328M | 50.46%117M | 251.70%77.76M | --22.11M | ---- | -45.04%8.62M | 193.83%15.68M | --5.34M |
-Other non-cash items | 0.45%2.21B | 124.46%2.2B | -52.15%981M | 99.38%2.05B | 41.02%1.03B | -3.02%729.12M | 72.87%751.83M | -24.52%434.9M | 6.31%576.2M | -67.46%541.99M |
Changes in working capital | -134.34%-12.32B | 45.97%-5.26B | -436.87%-9.73B | 7.03%-1.81B | -563.22%-1.95B | -74.34%420.75M | 329.75%1.64B | 112.70%381.52M | -201.45%-3B | 358.80%2.96B |
-Change in receivables | -56.71%-4.92B | 26.28%-3.14B | 69.07%-4.26B | -4,703.37%-13.77B | 114.54%299.09M | 15.52%-2.06B | -137.57%-2.44B | 1.66%-1.03B | -166.39%-1.04B | -54.67%1.57B |
-Change in inventory | 63.93%-5.18B | -57.29%-14.35B | -174.55%-9.13B | -150.26%-3.32B | -745.12%-1.33B | 93.97%-157.17M | -490.95%-2.6B | 239.11%666.21M | -1.98%-478.9M | 55.66%-469.61M |
-Change in payables | -168.63%-4.47B | 7.44%6.52B | -21.50%6.07B | 761.32%7.73B | -175.70%-1.17B | -60.75%1.54B | 51.01%3.93B | 211.26%2.6B | -402.50%-2.34B | 180.39%773.61M |
-Provision for loans, leases and other losses | -57.25%333M | 297.45%779M | 126.92%196M | -208.21%-728M | 139.42%672.77M | -199.74%-1.71B | 1,896.86%1.71B | 8.01%85.7M | -87.72%79.34M | 126.02%646.32M |
-Changes in other current assets | -161.18%-1.55B | 159.95%2.54B | -182.75%-4.24B | 3,822.65%5.12B | 107.98%130.52M | -64.84%-1.64B | 33.02%-992.65M | -305.68%-1.48B | -243.60%-365.33M | 1,402.62%254.41M |
-Changes in other current liabilities | 44.55%3.47B | 47.18%2.4B | -48.39%1.63B | 669.91%3.16B | -112.51%-554.83M | 118.58%4.44B | 534.70%2.03B | -140.79%-466.79M | 516.54%1.14B | 256.92%185.59M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -90.73%-1.85B | -19.14%-971M | 43.56%-815M | -56.26%-1.44B | -23.01%-924.1M | -18.34%-751.24M | -21.61%-634.84M | 3.54%-522.03M | 3.29%-541.18M | 6.31%-559.58M |
Interest received (cash flow from operating activities) | 262.41%2.13B | 69.94%588M | 86.02%346M | 171.22%186M | -21.80%68.58M | 41.84%87.7M | 52.98%61.83M | -35.87%40.42M | 82.91%63.03M | -30.76%34.46M |
Tax refund paid | 14.77%-5.97B | -70.60%-7B | -53.80%-4.11B | -41.94%-2.67B | 47.89%-1.88B | -66.78%-3.61B | -26.30%-2.16B | -114.98%-1.71B | 0.57%-796.76M | -74.73%-801.36M |
Other operating cash inflow (outflow) | 0 | 0.00%-1M | -1M | 0 | 72.24%507.35M | 24.57%294.55M | 23,646,200.00%236.46M | 0.00%-1K | 0.00%-1K | 0.00%-1K |
Operating cash flow | -33.25%28.72B | 141.26%43.02B | 34.92%17.83B | 48.46%13.22B | -22.35%8.9B | 15.27%11.47B | 21.04%9.95B | 77.03%8.22B | -40.70%4.64B | 99.33%7.83B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -33.11%-74.23B | -68.04%-55.77B | -148.08%-33.19B | 60.38%-13.38B | 2.99%-33.76B | -217.25%-34.81B | -51.27%-10.97B | -124.10%-7.25B | -7.63%-3.24B | 19.10%-3.01B |
Net intangibles purchase and sale | 24.49%-737M | -343.64%-976M | -113.59%-220M | 16.95%-103M | 89.14%-124.03M | 5.87%-1.14B | -16,314.21%-1.21B | ---7.39M | ---- | ---- |
Net business purchase and sale | -159.59%-758M | 77.15%-292M | 84.03%-1.28B | ---8B | ---- | ---764.54M | ---- | 225.28%314.8M | -559.89%-251.27M | 88.54%-38.08M |
Net investment product transactions | -38.61%-16.13B | -5,689.05%-11.64B | -20,000.00%-201M | -100.71%-1M | 196.93%141.22M | 188.45%47.56M | -595.18%-53.77M | 150.94%10.86M | 88.95%-21.32M | -113.72%-192.97M |
Advance cash and loans provided to other parties | ---67M | --0 | ---- | 99.85%-1M | -106,082.10%-658.33M | 38.00%-620K | ---1M | ---- | -852.38%-20M | 99.74%-2.1M |
Repayment of advance payments to other parties and cash income from loans | 250.00%14M | -99.93%4M | 794.52%5.55B | 24,829.63%620M | -13.28%2.49M | -91.34%2.87M | -18.87%33.13M | -38.42%40.84M | 13.64%66.32M | -92.78%58.36M |
Net changes in other investments | -418.95%-493M | -55.74%-95M | -281.25%-61M | 76.96%-16M | 82.67%-69.43M | -119.15%-400.77M | -3.65%-182.87M | 68.55%-176.44M | -51.20%-561.05M | -136.58%-371.07M |
Investing cash flow | -34.38%-92.4B | -133.89%-68.76B | -40.81%-29.4B | 39.43%-20.88B | 6.99%-34.47B | -199.17%-37.06B | -75.22%-12.39B | -75.72%-7.07B | -13.26%-4.02B | -26.27%-3.55B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 66.03%41.47B | 357.81%24.97B | 58.45%-9.69B | -270.07%-23.31B | -61.74%13.71B | 1,077.62%35.83B | -32.46%3.04B | 2,842.79%4.5B | 91.18%-164.22M | -13.31%-1.86B |
Net common stock issuance | 290.00%39M | -99.95%10M | 25,260.53%19.27B | 104.99%76M | 563.48%37.08M | -99.94%5.59M | 44,637.08%8.71B | --19.48M | ---- | ---- |
Increase or decrease of lease financing | 71.98%-95M | -130.61%-339M | 9.26%-147M | 30.23%-162M | -83.79%-232.18M | 20.64%-126.33M | -39.70%-159.18M | -5.63%-113.94M | -68.07%-107.87M | -15.45%-64.18M |
Cash dividends paid | -39.44%-4.93B | -125.98%-3.53B | -75.62%-1.56B | -0.34%-890M | 0.01%-887.01M | -9.27%-887.08M | -64.88%-811.79M | -97.89%-492.35M | -34.42%-248.8M | -19.36%-185.09M |
Cash dividends for minorities | ---303M | --0 | ---19M | --0 | ---8.96M | ---- | -25.88%-24.48M | ---19.45M | ---- | ---- |
Net other fund-raising expenses | -49.09%24.24B | 109.32%47.61B | -50.54%22.74B | 754.82%45.98B | 1,824.60%5.38B | -538.05%-311.91M | 2,373,600.00%71.21M | -50.00%-3K | 99.68%-2K | -61,900.00%-620K |
Financing cash flow | -12.08%60.42B | 124.56%68.72B | 41.06%30.6B | 20.55%21.69B | -47.85%18B | 218.61%34.51B | 177.85%10.83B | 848.32%3.9B | 75.33%-520.9M | -13.44%-2.11B |
Net cash flow | ||||||||||
Beginning cash position | 82.40%95.91B | 74.09%52.58B | 27.39%30.2B | -24.87%23.71B | 33.44%31.56B | 60.02%23.65B | 47.22%14.78B | -4.56%10.04B | 39.29%10.52B | 2.41%7.55B |
Current changes in cash | -107.59%-3.26B | 125.81%42.98B | 35.65%19.04B | 285.28%14.03B | -185.00%-7.57B | 6.21%8.91B | 66.25%8.39B | 5,062.70%5.05B | -95.49%97.74M | 389.88%2.17B |
Effect of exchange rate changes | 1,109.88%4.16B | -89.70%344M | 1,820.11%3.34B | 143.98%174M | 60.56%-395.66M | -338.21%-1B | 237.63%421.1M | 46.96%-305.97M | -171.95%-576.85M | -13.28%801.76M |
Cash adjustments other than cash changes | ---- | ---- | 100.01%1M | -6,397.82%-7.71B | --122.47M | ---- | --60M | ---- | -200.00%-1K | 0.00%1K |
End cash Position | 0.94%96.81B | 82.40%95.91B | 74.09%52.58B | 27.39%30.2B | -24.87%23.71B | 33.44%31.56B | 60.02%23.65B | 47.22%14.78B | -4.56%10.04B | 39.29%10.52B |
Free cash flow | -233.30%-46.51B | 12.76%-13.95B | -1,382.21%-15.99B | 95.69%-1.08B | -2.17%-25.02B | -940.57%-24.49B | -364.81%-2.35B | -26.07%888.61M | -73.01%1.2B | 4,248.01%4.45B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |